Aunque es invisible a nuestros ojos, la luz infrarroja de onda corta (o SWIR, por sus siglas en inglés) puede permitir una viabilidad, funcionalidad y rendimiento sin precedentes de las aplicaciones de visión por computador de alto volumen para los mercados de la robótica de ser …
From the rising trend of royalty financing to other adaptive funding strategies, firms think outside the box in responding to unprecedented challenges.
Biotech Gets Creative to Avoid Bankruptcy in 2024 Read More »
El observatorio espacial XRISM todavía no ha empezado a trabajar, pero la fase de comprobaciones y calibración está terminando y ya ha obtenido algunas imágenes de prueba, que constituyen un espectacular adelanto de lo que vendrá. El satélite astron …
Brand pharmas not only leverage ancillary patents but sometimes hide or misrepresent information to the U.S. patent office in order to extend market exclusivity and high prices.
Companies Bend Patent System to Head Off Competition Long-Term: Analysis Read More »
The affiliate of the Multidisciplinary Association for Psychedelic Studies launched the fundraising effort to support its New Drug Application for an investigational, MDMA-assisted therapy for post-traumatic stress disorder.
The BioSpace team is recording from San Francisco as they bring you the the latest highlights from Day 2 at JPM2024.
As the second day of the 42nd J.P. Morgan Healthcare Conference dawned in San Francisco, experts from Boston Consulting Group, Merck, CVC and more provided their outlook on the year ahead.
AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel Read More »
The study could support extending acute hospital care at home, researchers said. Currently, a pandemic-era waiver for the programs is set to expire at the end of the year.
Mortality rates low for hospital-at-home patients, study finds Read More »
The J&J unit limited the use of the product in children after receiving reports of burn injuries that could be particularly harmful to them.
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice Read More »
“Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.
Medtronic focused on delivering durable revenue and profit growth Read More »
